Dexamethasone Sodium Phosphate Injection Shortage
Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.
| Company | Brand name | Status | Last updated |
|---|---|---|---|
| Fresenius Kabi USA, LLC | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/21/2026 |
| Fresenius Kabi USA, LLC | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/21/2026 |
| Fresenius Kabi USA, LLC | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/21/2026 |
| Fresenius Kabi USA, LLC | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/21/2026 |
| Fresenius Kabi USA, LLC | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/21/2026 |
| Fresenius Kabi USA, LLC | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/21/2026 |
| Fresenius Kabi USA, LLC | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/21/2026 |
| Fresenius Kabi USA, LLC | — | Current | 07/21/2026 |
| Fresenius Kabi USA, LLC | — | Current | 07/21/2026 |
| Somerset Therapeutics, LLC | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/20/2026 |
| Somerset Therapeutics, LLC | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/20/2026 |
| Eugia US LLC | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/20/2026 |
| Mylan Institutional, a Viatris Company | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/17/2026 |
| Mylan Institutional, a Viatris Company | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/17/2026 |
| Mylan Institutional, a Viatris Company | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/17/2026 |
| Mylan Institutional, a Viatris Company | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/17/2026 |
| Hikma Pharmaceuticals USA, Inc. | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | DEXAMETHASONE SODIUM PHOSPHATE | Current | 07/13/2026 |